1364 related articles for article (PubMed ID: 29902132)
1. Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia.
Wang A; Zhong H
Hematology; 2018 Dec; 23(10):729-739. PubMed ID: 29902132
[TBL] [Abstract][Full Text] [Related]
2. Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion.
Kumar B; Garcia M; Weng L; Jung X; Murakami JL; Hu X; McDonald T; Lin A; Kumar AR; DiGiusto DL; Stein AS; Pullarkat VA; Hui SK; Carlesso N; Kuo YH; Bhatia R; Marcucci G; Chen CC
Leukemia; 2018 Mar; 32(3):575-587. PubMed ID: 28816238
[TBL] [Abstract][Full Text] [Related]
3. Role of Microenvironment in Resistance to Therapy in AML.
Tabe Y; Konopleva M
Curr Hematol Malig Rep; 2015 Jun; 10(2):96-103. PubMed ID: 25921386
[TBL] [Abstract][Full Text] [Related]
4. The bone marrow microenvironment - Home of the leukemic blasts.
Shafat MS; Gnaneswaran B; Bowles KM; Rushworth SA
Blood Rev; 2017 Sep; 31(5):277-286. PubMed ID: 28318761
[TBL] [Abstract][Full Text] [Related]
5. A Role for the Bone Marrow Microenvironment in Drug Resistance of Acute Myeloid Leukemia.
Bolandi SM; Pakjoo M; Beigi P; Kiani M; Allahgholipour A; Goudarzi N; Khorashad JS; Eiring AM
Cells; 2021 Oct; 10(11):. PubMed ID: 34831055
[TBL] [Abstract][Full Text] [Related]
6. Adipogenic Mesenchymal Stromal Cells from Bone Marrow and Their Hematopoietic Supportive Role: Towards Understanding the Permissive Marrow Microenvironment in Acute Myeloid Leukemia.
Le Y; Fraineau S; Chandran P; Sabloff M; Brand M; Lavoie JR; Gagne R; Rosu-Myles M; Yauk CL; Richardson RB; Allan DS
Stem Cell Rev Rep; 2016 Apr; 12(2):235-44. PubMed ID: 26649729
[TBL] [Abstract][Full Text] [Related]
7. The relevance of the hematopoietic niche for therapy resistance in acute myeloid leukemia.
Allert C; Müller-Tidow C; Blank MF
Int J Cancer; 2024 Jan; 154(2):197-209. PubMed ID: 37565773
[TBL] [Abstract][Full Text] [Related]
8. Distinct roles of mesenchymal stem and progenitor cells during the development of acute myeloid leukemia in mice.
Xiao P; Sandhow L; Heshmati Y; Kondo M; Bouderlique T; Dolinska M; Johansson AS; Sigvardsson M; Ekblom M; Walfridsson J; Qian H
Blood Adv; 2018 Jun; 2(12):1480-1494. PubMed ID: 29945938
[TBL] [Abstract][Full Text] [Related]
9. TGF-β1 and CXCL12 modulate proliferation and chemotherapy sensitivity of acute myeloid leukemia cells co-cultured with multipotent mesenchymal stromal cells.
Schelker RC; Iberl S; Müller G; Hart C; Herr W; Grassinger J
Hematology; 2018 Jul; 23(6):337-345. PubMed ID: 29140182
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?
Pleyer L; Valent P; Greil R
Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27355944
[TBL] [Abstract][Full Text] [Related]
11. c-Myc plays part in drug resistance mediated by bone marrow stromal cells in acute myeloid leukemia.
Xia B; Tian C; Guo S; Zhang L; Zhao D; Qu F; Zhao W; Wang Y; Wu X; Da W; Wei S; Zhang Y
Leuk Res; 2015 Jan; 39(1):92-9. PubMed ID: 25443862
[TBL] [Abstract][Full Text] [Related]
12. Acute myeloid leukemia-induced remodeling of the human bone marrow niche predicts clinical outcome.
Chen Y; Hoffmeister LM; Zaun Y; Arnold L; Schmid KW; Giebel B; Klein-Hitpass L; Hanenberg H; Squire A; Reinhardt HC; Dührsen U; Bertram S; Hanoun M
Blood Adv; 2020 Oct; 4(20):5257-5268. PubMed ID: 33108453
[TBL] [Abstract][Full Text] [Related]
13. Osteogenic niche in the regulation of normal hematopoiesis and leukemogenesis.
Le PM; Andreeff M; Battula VL
Haematologica; 2018 Dec; 103(12):1945-1955. PubMed ID: 30337364
[TBL] [Abstract][Full Text] [Related]
14. Understanding of the crosstalk between normal residual hematopoietic stem cells and the leukemic niche in acute myeloid leukemia.
Batsivari A; Grey W; Bonnet D
Exp Hematol; 2021 Mar; 95():23-30. PubMed ID: 33497761
[TBL] [Abstract][Full Text] [Related]
15. AML alters bone marrow stromal cell osteogenic commitment via Notch signaling.
Tomasoni C; Arsuffi C; Donsante S; Corsi A; Riminucci M; Biondi A; Pievani A; Serafini M
Front Immunol; 2023; 14():1320497. PubMed ID: 38111584
[TBL] [Abstract][Full Text] [Related]
16. Tumor Microenvironment in Acute Myeloid Leukemia: Adjusting Niches.
Menter T; Tzankov A
Front Immunol; 2022; 13():811144. PubMed ID: 35273598
[TBL] [Abstract][Full Text] [Related]
17. The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients.
Hoang VT; Buss EC; Wang W; Hoffmann I; Raffel S; Zepeda-Moreno A; Baran N; Wuchter P; Eckstein V; Trumpp A; Jauch A; Ho AD; Lutz C
Int J Cancer; 2015 Aug; 137(3):525-36. PubMed ID: 25545165
[TBL] [Abstract][Full Text] [Related]
18. Exploiting epigenetically mediated changes: Acute myeloid leukemia, leukemia stem cells and the bone marrow microenvironment.
Kogan AA; Lapidus RG; Baer MR; Rassool FV
Adv Cancer Res; 2019; 141():213-253. PubMed ID: 30691684
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stromal cells from patients with acute myeloid leukemia have altered capacity to expand differentiated hematopoietic progenitors.
Chandran P; Le Y; Li Y; Sabloff M; Mehic J; Rosu-Myles M; Allan DS
Leuk Res; 2015 Apr; 39(4):486-93. PubMed ID: 25703353
[TBL] [Abstract][Full Text] [Related]
20. Transforming the Niche: The Emerging Role of Extracellular Vesicles in Acute Myeloid Leukaemia Progression.
Mendes M; Monteiro AC; Neto E; Barrias CC; Sobrinho-Simões MA; Duarte D; Caires HR
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]